Leerink Swann restated their outperform rating on shares of AC Immune Ltd (NASDAQ:ACIU) in a research note published on Saturday morning.

Other equities analysts also recently issued reports about the stock. Credit Suisse Group AG initiated coverage on shares of AC Immune in a report on Tuesday, October 18th. They issued an outperform rating and a $18.00 target price for the company. Jefferies Group initiated coverage on shares of AC Immune in a report on Tuesday, October 18th. They issued a buy rating and a $25.00 target price for the company.

Shares of AC Immune (NASDAQ:ACIU) traded up 9.37% during trading on Friday, hitting $12.61. 269,075 shares of the stock traded hands. AC Immune has a 52-week low of $10.36 and a 52-week high of $19.97. The stock has a 50 day moving average of $14.16 and a 200 day moving average of $14.83. The firm’s market cap is $624.74 million.

TRADEMARK VIOLATION WARNING: “AC Immune’s (ACIU) “Outperform” Rating Reaffirmed at Leerink Swann” was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/26/ac-immunes-aciu-outperform-rating-reaffirmed-at-leerink-swann.html.

5 Day Chart for NASDAQ:ACIU

Receive News & Stock Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related stocks with our FREE daily email newsletter.